Login

Watch NRG Energy CEO Mauricio Gutierrez discuss #EmbracingSustainability at NRG and challenge Steve Mollenkopf to share their sustainability efforts. 00:10:00

Share On Facebook Share On Twitter

Mauricio Gutierrez, CEO of NRG Energy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights into Liontrust Asset Management PLC: Investor Presentation
00:10:00
Ezdan Holding's Strategic Approach and Investor Appeal Highlighted in Recent Debut Offering | ALI MOHAMMED AL OBAIDLI, CEO,Ezdan Holding Group.
00:10:00
How the Trade Commissioner Service Accelerates Global Expansion for Canadian Tech Companies
00:10:00
Invests in seed to growth stage startups that uses tech to disrupt existing markets or create entirely new ones|Aaref Hilaly,Partner,Bain Capital Ventures
00:10:00
3R Petroleum: How do the company's processes work? | Matheus Dias de Siqueira, CEO, 3R Petroleum Oleo e Gas SARRRP3:SAO
00:10:00
Technology Metals Australia: Pioneering Vanadium Mining in Western Australia
00:10:00
Challenging the Myths of the Great Depression|Amity Shlaes
00:10:00
Managing Derector Eric Yong , Crest Builder Holdings Berhad
00:00:00
BioPorto CEO explains why he's expecting 2021 to be a 'pivotal year - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:10:00
Helium One's Strategic Approach to Helium Production in Tanzania: Insights from the 121 Conference
00:10:00
Entrepreneurs to build companies addressing climate and sustainability challenges|Joshua Posamentier,Co-Founder and Managing Partner,Congruent Ventures
00:10:00
CEO Juha Saarela Highlights Key Drivers of Puuilo's Q1 Success in New Fiscal Year | Juha Saarela, CEO, Puuil OYj.

© 2017 - Neuhu+